Excipient Market Overview: Roquette announces restructuring post IFF Pharma buyout; WHO, FDA advance regulatory frameworks

Data Compilation
#PharmaFlow

Pipeline Prospector May 2025: Pfizer strikes US$ 6 bn oncology pact; Lilly diversifies pipeline with US$ 2.3 bn in deals

Stock Recap
#PipelineProspector

4-[(1R)-2-(tert-butylamino)-1-hydroxyethyl]-2-(hydroxymethyl)phenol;sulfuric acid

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

71 API Suppliers, 27 USDMF, 11 CEP/COS, 1 JDMF, 11 EU WC, 2 KDMF, 22 NDC API, 38 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

25 Drugs in Development

25 Drugs in Development

INTERMEDIATES

2 Intermediate Suppliers

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

395 FDF Dossiers, 135 FDA Orange Book, 109 Europe, 21 Canada, 18 Australia, 42 South Africa, 70 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

AEROSOL, METERED;INHALATION - EQ 0.09MG BASE/INH, SOLUTION;INHALATION - EQ 0.083% BASE;0.017% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, AEROSOL, METERED;INHALATION - EQ 0.09MG BASE/INH, AEROSOL, METERED;INHALATION - EQ 0.09MG BASE/INH

RELATED EXCIPIENT COMPANIES

3 Rochem International Inc, 6 SPI Pharma, 10 DKSH, 1 Pharm-RX Chemical, 4 Faran Shimi Pharmaceutical, 5 Gangwal Healthcare, 4 Nanjing Well Pharmaceutical, 1 ACG Worldwide, 11 Actylis, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 17 BASF, 11 Corel Pharma Chem, 6 DFE Pharma, 3 Finar, 6 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 3 Ingredion Pharma Solutions, 35 Kerry, 4 Kima Chemical, 6 Lonza Capsugel, 13 Microlex e.U, 2 Nomisma Healthcare, 1 Novo Excipients, 2 Pharmatrans-Sanaq, 4 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 26 Roquette, 8 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 9 Sigachi Industries, 3 Silverline Chemicals, 3 The Dow Chemical Company, 1 Valens Pharmachem, 3 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

62 Fillers, Diluents & Binders, 49 Coating Systems & Additives, 28 Controlled & Modified Release, 23 Thickeners and Stabilizers, 20 Granulation, 20 Direct Compression, 19 Film Formers & Plasticizers, 18 Taste Masking, 17 Disintegrants & Superdisintegrants, 16 Lubricants & Glidants, 16 Co-Processed Excipients, 15 Topical, 10 Solubilizers, 9 Parenteral, 8 Chewable & Orodispersible Aids, 6 Emulsifying Agents, 6 Rheology Modifiers, 5 Empty Capsules, 5 API Stability Enhancers, 5 Coloring Agents, 4 Vegetarian Capsules, 1 Soft Gelatin, 1 Surfactant & Foaming Agents

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 91 News #PharmaBuzz

GLOBAL SALES INFORMATION

4 US Medicaid Prescriptions, 92 Regulatory FDF Prices, 19 Annual Reports

MARKET PLACE

31 APIs, 14 FDF Dossiers, 1 EXCIPIENTS

PATENTS & EXCLUSIVITIES

36 US Patents, 5 Health Canada Patents

REF. STANDARDS & IMPURITIES

5 EDQM, 23 Others

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Certificate Holder	Certificate No.	Substance	Issue Date	Status	Type	End Date	Substance No.
04/06/2025	Supriya Lifescience	India	SUPRIYA LIFESCIENCE LTD. Mumbai IN	CEP 2019-037 - Rev 01	Salbutamol sulfate	2024-09-25	Valid	Chemical		687
04/06/2025	Boehringer Ingelheim GmbH	Germany	Boehringer Ingelheim Pharma GmbH & Co. KG Ingelheim Am Rhein DE	CEP 1997-004 - Rev 05	Salbutamol sulfate	2024-05-30	Valid	Chemical		687

4-[(1R)-2-(tert-butylamino)-1-hydroxyethyl]-2-(hydroxymethyl)phenol;sulfuric Acid

4-[(1R)-2-(tert-butylamino)-1-hydroxyethyl]-2-(hydroxymethyl)phenol;sulfuric acid

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

71 API Suppliers

27 USDMF

11 CEP/COS

1 JDMF

11 EU WC

2 KDMF

22 NDC API

38 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

25 Drugs in Development

INTERMEDIATES

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

395 FDF Dossiers

135 FDA Orange Book

109 Europe

21 Canada

18 Australia

42 South Africa

70 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

AEROSOL, METERED;INHALATION - EQ 0.09MG BASE/INH

SOLUTION;INHALATION - EQ 0.083% BASE;0.017% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

AEROSOL, METERED;INHALATION - EQ 0.09MG BASE/INH

AEROSOL, METERED;INHALATION - EQ 0.09MG BASE/INH

RELATED EXCIPIENT COMPANIES

3 Rochem International Inc

6 SPI Pharma

10 DKSH

1 Pharm-RX Chemical

4 Faran Shimi Pharmaceutical

5 Gangwal Healthcare

4 Nanjing Well Pharmaceutical

1 ACG Worldwide

11 Actylis

6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

17 BASF

11 Corel Pharma Chem

6 DFE Pharma

3 Finar

6 Gangwal Chemicals

5 Ideal Cures Pvt Ltd

3 Ingredion Pharma Solutions

35 Kerry

4 Kima Chemical

6 Lonza Capsugel

13 Microlex e.U

2 Nomisma Healthcare

1 Novo Excipients

2 Pharmatrans-Sanaq

4 Pluviaendo

3 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

1 Qualicaps

26 Roquette

8 Seppic

4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shijiazhuang Huaxu Pharmaceutical

9 Sigachi Industries

3 Silverline Chemicals

3 The Dow Chemical Company

1 Valens Pharmachem

3 Vasa Pharmachem

1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

62 Fillers, Diluents & Binders

49 Coating Systems & Additives

28 Controlled & Modified Release

23 Thickeners and Stabilizers

20 Granulation

20 Direct Compression

19 Film Formers & Plasticizers

SOLUTION;INHALATION - EQ 0.083% BASE;0.017% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons